Location History:
- Washington Township, NJ (US) (2008 - 2023)
- Township of Washington, NJ (US) (2022 - 2023)
Company Filing History:
Years Active: 2008-2023
Title: Inventor Spotlight: Tahseen A Chowdhury
Introduction
Tahseen A Chowdhury is a notable inventor based in Washington Township, NJ, USA. With a remarkable portfolio of 15 patents, his contributions notably advance pharmaceutical innovations, particularly in drug delivery systems.
Latest Patents
One of his latest inventions is the oral eliglustat transmucosal delivery system. This innovative dosage form comprises a non-disintegrating solid mass that includes a hydrophilic viscosity modifying agent, a low molecular weight water-soluble component, and a limited amount of eliglustat. Unlike commercially available eliglustat capsules, this formulation allows for administration without pre-determination of the patient's CYP2D6 genotype, offering a streamlined approach for patients with Gaucher disease type 1. Another notable patent involves long-acting injectable formulations featuring poorly water-soluble active pharmaceutical ingredients. These extended-release formulations utilize a non-aqueous liquid vehicle, designed for thixotropic behavior and enhanced drug dispersibility.
Career Highlights
Throughout his career, Tahseen has contributed to several reputable companies, including Abon Pharmaceuticals LLC and Teva Women's Health, Inc. His work has significantly influenced the development of innovative pharmaceutical solutions, thereby improving patient care and treatment efficacy.
Collaborations
In his innovative journey, Tahseen has collaborated with several professionals, including Salah Uddin Ahmed and Yanming Zu. These partnerships reflect a commitment to interdisciplinary research and the coupling of diverse expertise in developing groundbreaking pharmaceutical technologies.
Conclusion
Tahseen A Chowdhury stands as a prominent figure in the realm of pharmaceutical inventions. With his 15 patents, particularly in drug delivery systems, he continues to make significant impacts in improving healthcare solutions. His collaborations and professional affiliations further highlight the collective effort in advancing pharmaceutical innovations.